150 related articles for article (PubMed ID: 24760579)
1. Inactivation of glycogen synthase kinase-3β up-regulates β-catenin and promotes chondrogenesis.
Zhou J; Chen Y; Cao C; Chen X; Gao W; Zhang L
Cell Tissue Bank; 2015 Mar; 16(1):135-42. PubMed ID: 24760579
[TBL] [Abstract][Full Text] [Related]
2. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression.
Gillespie JR; Ulici V; Dupuis H; Higgs A; Dimattia A; Patel S; Woodgett JR; Beier F
Endocrinology; 2011 May; 152(5):1755-66. PubMed ID: 21325041
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
Cho YJ; Yoon J; Ko YS; Kim SY; Cho SJ; Kim WH; Park JW; Youn HD; Kim JH; Lee BL
APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473
[TBL] [Abstract][Full Text] [Related]
4. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes.
Kawasaki Y; Kugimiya F; Chikuda H; Kamekura S; Ikeda T; Kawamura N; Saito T; Shinoda Y; Higashikawa A; Yano F; Ogasawara T; Ogata N; Hoshi K; Hofmann F; Woodgett JR; Nakamura K; Chung UI; Kawaguchi H
J Clin Invest; 2008 Jul; 118(7):2506-15. PubMed ID: 18551195
[TBL] [Abstract][Full Text] [Related]
9. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
Cao Q; Feng YJ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
[TBL] [Abstract][Full Text] [Related]
10. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
[TBL] [Abstract][Full Text] [Related]
11. Ischemic preconditioning increases GSK-3β/β-catenin levels and ameliorates liver ischemia/reperfusion injury in rats.
Yan Y; Li G; Tian X; Ye Y; Gao Z; Yao J; Zhang F; Wang S
Int J Mol Med; 2015 Jun; 35(6):1625-32. PubMed ID: 25813855
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
14. ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3β and β-catenin pathway.
Boku S; Nakagawa S; Toda H; Kato A; Takamura N; Omiya Y; Inoue T; Koyama T
Brain Res; 2013 Jan; 1492():7-17. PubMed ID: 23211630
[TBL] [Abstract][Full Text] [Related]
15. Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin.
Ren X; Rizavi HS; Khan MA; Dwivedi Y; Pandey GN
Int J Neuropsychopharmacol; 2013 Jun; 16(5):945-55. PubMed ID: 23110823
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
17. Acceleration of bone development and regeneration through the Wnt/β-catenin signaling pathway in mice heterozygously deficient for GSK-3β.
Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Takashima A; Mori Y; Sasaguri T
Biochem Biophys Res Commun; 2013 Nov; 440(4):677-82. PubMed ID: 24099767
[TBL] [Abstract][Full Text] [Related]
18. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells.
Zhang X; Yin WK; Shi XD; Li Y
Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
[TBL] [Abstract][Full Text] [Related]
20. Regulation of β-catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop.
Jamieson C; Sharma M; Henderson BR
Traffic; 2011 Aug; 12(8):983-99. PubMed ID: 21496192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
